Drug Profile
Brinzolamide/timolol
Alternative Names: Azarga; Elazop; Timolol/brinzolamideLatest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Alcon
- Developer Novartis
- Class Amino alcohols; Antiglaucomas; Morpholines; Propanolamines; Sulfonamides; Thiadiazoles; Thiazines
- Mechanism of Action Beta-adrenergic receptor antagonists; Carbonic anhydrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Glaucoma; Ocular hypertension
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon eye care devices business
- 06 Sep 2016 No recent reports on development identified - Phase-III for Glaucoma and Ocular hypertension in USA (Ophthalmic)
- 17 Apr 2013 Launched for Glaucoma in Malaysia, Singapore, Thailand, Taiwan and South Korea (Ophthalmic) prior to April 2013